policy
Guidelines for use of autogenous biologics
Autogenous biological products may provide veterinarians a unique opportunity for control of certain infectious diseases when USDA-licensed commercial…
policy
Guidelines for use of exempt biologics
State-licensed veterinarians may consider preparing biologics in their practice facility under a VCPR in unique disease situations not adequately…
policy
Development of emerging disease agent biologics
Development of emerging infectious disease biologics is essential for One Health. The AVMA supports the development of these products through…
JAVMA news
Editing Animals
Recent gene-editing technologies are being used to create mice that model human genetic diseases, Holstein cattle lacking horns, and current research…
JAVMA news
FDA extends call for treatment limit ideas
Food and Drug Administration authorities have extended a call for ideas on how to limit durations of some approved antimicrobial treatments in…
JAVMA news
Laboratories certified, rapid tests approved for BSE surveillance
Department of Agriculture has approved seven state veterinary diagnostic laboratories
JAVMA news
Summit paints mixed economic picture for practitioners
There’s good news: Revenues are growing at many veterinary practices.There's mixed news: The AVMA Veterinary Career Center now has more jobs than…
JAVMA news
Candidate vaccine protects pigs against African swine fever strains
A U.S. Department of Agriculture–developed vaccine against African swine fever protected pigs in a second study, suggesting progress toward a…
AVMA news
Raw pet food diets, pet population management policies headed to HOD
The AVMA House of Delegates, during its regular winter session, being held January 5-6, 2024, in Chicago, will vote on six resolutions that would…